The New York Stock Exchange today welcomed Mindray Medical International Limited to the NYSE, where the company’s IPO raised $270 million. Mindray Medical, a leading medical device designer and manufacturer in
“Since the NYSE is the premier listing market for worldwide companies, it is best matched with our strategy to become a global company,” said Mindray Medical International Chairman Hang Xu, who rang today’s Opening Bell at the NYSE.
“We welcome Mindray Medical International to our family of listed companies,” said NYSE CEO John A. Thain. “We look forward to an outstanding partnership with Mindray Medical International, and to providing the company with the outstanding market quality and superior visibility that issuers from around the world have come to expect from listing on the New York Stock Exchange.”
Headquartered in Shenzhen, Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in
The company has offices in 29 major cities of
Mindray is the latest in the roster of high-growth entrepreneurial Chinese companies to be listed on the New York Stock Exchange, bringing the number of companies from Mainland